- EFA continues to be the only patient organisation working with European Chemicals Agency
- The European Chemicals Agency (ECHA) organised its annual Accredited Stakeholder Workshop on 21 March 2019 in Brussels to mainly discuss ECHA’s Strategic Plan 2019-2023 with official stakeholders, lik ...
- New IMI Project: 3TR
- Despite the wide availability of treatments for autoimmune, inflammatory and allergic diseases, the response to therapy and the disease progression is unpredictable and varies from patient to patient. ...
- New COPD development prediction: the ALEC Project
- Although COPD has long been viewed as a predominantly smoking-related disease, there is increasing awareness that lifestyle and the environment contribute to the development of the disease already fro ...
- Our takeaways from the ERS Satellite on COPD
- FA took part in the last Satellite Precision Medicine training, organised by the European Respiratory Society (ERS) to deliver free cutting-edge education using live-streaming technology. This one day ...
- Asthma UK: Stop unfair asthma prescription charges
- EFA Member Asthma UK has launched a petition to stop unfair asthma prescription charges. By now, some 55,000 people have already signed and supported the initiative! Click here if you want to suppor ...
- European Commission Manual for patients: Patients’ rights to accessing healthcare
- The European Commission Directorate General for Health and Food Safety (DG SANTE) has published a manual for patients regarding their rights to access healthcare in any EU/EEA country different from t ...
- Rare diseases: A new platform to support better diagnosis and treatment
- In light of the Rare Disease Day in February, the European Commission has launched a new online knowledge-sharing platform to support better diagnosis and treatment for more than 30 million Europeans ...
- Asthma Allergy Denmark: Hay-fever and allergy high-school 2019
- EFA Member Astma Allergi Denmark organises a Hay-fever and Allergy High School. During the event, attendees can ask questions and get advice from Astma-Allergy Denmark. The goal of the ‘High School’ i ...
- European Food Safety Authority discusses civil society concerns
- The use and presence of pesticides, and their classification as endocrine disruptors where among the top food-related health concerns that civil society representatives discussed with European Safety ...
- EFA calls for a European Air Quality strategy at the European Health Parliament
- EFA was invited to bring the perspective of allergy and airways diseases patients to a debate on environment and human health at the 3rd Plenary of the European Health Parliament, an advocacy forum co ...
- EU digital prescriptions system kicks off in Finland and Estonia
- We welcome the initiative giving patients the possibility to use digital prescriptions: prescriptions issued by a doctor at home can be issued when going to a pharmacist in another EU member state. ...
- Exposure to 25 carcinogens and mutagens will be reduced in the workplace
- The third round of amendments on the Directive on Carcinogens and Mutagens at Work came to a close late January. The legislation seeks to impose obligatory occupational exposure limit values on danger ...
- European Medicines Agency reloactes to Amsterdam in March
- The European Medicines Agency relocates to Amsterdam. The process will be completed by mid-March 2019. According to an EMA press release, the Dutch authorities have already handed over the temporary s ...
- Environmental agency calls for action to protect Europeans from air pollution and noise
- Better alignment of social and environment policies and improved local action is necessary to tackle environmental justice issues. These are the results of a report issued by the European Environment ...
- COP24 reports how much climate change and fossil fuels harm our respiratory health
- The World Health Organisation (WHO) COP24 special report on health and climate change shows that climate change undermines people’s access to clean air, safe drinking-water, sufficient food and secure ...
- New EFA publication: the impact of Atopic Eczema on daily life
- Atopic eczema is one of the most common non-communicable inflammatory diseases. Still, its impact on patients’ lives is often underestimated and ignored. In 2018, we studied the impact severe atopic e ...
- Quaterly Summary from EFA Working Groups
- In December 2018 and January 2019 we organised follow-up calls with EFA Working Groups to discuss hot topics and share national experiences important for allergy and airways diseases patients. Food ...
- Asthma Society of Ireland launches social media campaigns on asthma and winter
- EFA Member the Asthma Society Ireland has had a quite busy start into 2019. In January, they were running two campaigns simultaneously, Operation Asthma and Winter Wellness. Operation Asthma aims to ...
- EFA trains allergy and airways diseases patient leaders at Meet and Greet the EU
- The upcoming EU elections provide great opportunities to strengthen the voice of people living with allergies and airways diseases across Europe. Hence, this years’ EFA Meet & Greet training on Ja ...
- Many obstacles remain to the involvement of patients in the ongoing EU HTA environment
- On January 16th, EFA attended the annual meeting of the Health Technology Assessment Network Stakeholder Pool, hosted by the European Commission. During the meeting, participants discussed about how t ...